The expanding demand for specific immunological research and therapeutic creation has spurred significant advances in recombinant cytokine generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently generated using various expression platforms, including prokaryotic hosts, mammalian cell lines, and baculovirus